High-sensitive cardiac troponin T as a marker of hemorrhagic complications in elderly patients anticoagulated for non-massive pulmonary embolism

Simona, Aurélien; Limacher, Andreas; Méan, Marie; Golaz, Olivier Georges; Bounameaux, Henri; Aujesky, Drahomir; Righini, Marc Philip; Vuilleumier, Nicolas

doi:10.1016/j.thromres.2019.11.006

Scientific article

English

High-sensitive cardiac troponin T as a marker of hemorrhagic complications in elderly patients anticoagulated for non-massive pulmonary embolism

ContributorsSimona, Aurélien; Limacher, Andreas; Méan, Marie; Golaz, Olivier Georges; Bounameaux, Henri; Aujesky, Drahomir; Righini, Marc Philip; Vuilleumier, Nicolas

Published inThrombosis Research, vol. 185, p. 5-12

Publication date2019

Abstract

Recent data have raised concerns about the risk/benefit ratio of thrombolysis in non-high risk pulmonary embolism patients due to increased serious bleeding events. Whether cardiac biomarkers could be of help for bleeding risk stratification in this setting remains elusive.

Keywords

Brain
Hemorrhage
Natriuretic peptide
Pulmonary embolism
RIETE score
Troponin T

Affiliation

Research group

Funding

Swiss National Science Foundation - 33CSO-122659/139470

Citation (ISO format)

SIMONA, Aurélien et al. High-sensitive cardiac troponin T as a marker of hemorrhagic complications in elderly patients anticoagulated for non-massive pulmonary embolism. In: Thrombosis Research, 2019, vol. 185, p. 5–12. doi: 10.1016/j.thromres.2019.11.006

Article (Published version)

Identifiers

PID : unige:136504
DOI : 10.1016/j.thromres.2019.11.006
PMID : 31731089

ISSN of the journal0049-3848

284views

0downloads

Creation12/12/2019 4:48:00 PM

First validation12/12/2019 4:48:00 PM

Update time03/15/2023 10:02:36 PM

Status update03/15/2023 10:02:35 PM

Last indexation01/17/2024 9:59:17 AM

Archive ouverte UNIGE

High-sensitive cardiac troponin T as a marker of hemorrhagic complications in elderly patients anticoagulated for non-massive pulmonary embolism

Recent data have raised concerns about the risk/benefit ratio of thrombolysis in non-high risk pulmonary embolism patients due to increased serious bleeding events. Whether cardiac biomarkers could be of help for bleeding risk stratification in this setting remains elusive.

Technical informations